You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 1321 Evaluation of a new co-cultured microbiome ecosystem therapy candidate (MaaT03X) for clinical testing as adjuvant/neoadjuvant to immune checkpoint inhibitors in solid tumors

Alerts

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Microbiome and Other Environmental Factors
1321 Evaluation of a new co-cultured microbiome ecosystem therapy candidate (MaaT03X) for clinical testing as adjuvant/neoadjuvant to immune checkpoint inhibitors in solid tumors
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address